Oruka Therapeutics, Inc.
ORKAPharmaceutical Preparations · SIC 2834 · CIK 0000907654
Revenue FY2025
—
Net Income
$(105.0M)
EPS (Basic)
—
Net Margin
—
ROE
-22.3%
Total Equity
$472.0M
Shares Out
66M
Oruka Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2004–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
RA Capital Management
RA Capital Management
$148.0M
0.9%
NEW
Viking Global Investors
Andreas Halvorsen
$143.1M
0.2%
(43.6%)
Holocene Advisors
Holocene Advisors
$29.1M
0.1%
+64.9%
Adage Capital Management
Adage Capital Management
$33.8M
0.0%
+86.8%
Capital World Investors
Capital World Investors
$323.7M
0.0%
NEW
Alps Advisors
Alps Advisors
$5.8M
0.0%
+54.8%
Insider Transactions
Reading stored insider transactions…